These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 6364759

  • 21. Haemodynamic effects of sustained treatment with prazosin and metoprolol, alone and in combination, in borderline hypertensive heart failure.
    Nelson GI, Donnelly GL, Hunyor SN.
    J Cardiovasc Pharmacol; 1982; 4(2):240-5. PubMed ID: 6175807
    [Abstract] [Full Text] [Related]

  • 22. Comparison of doxazosin and atenolol in mild hypertension, and effects on exercise capacity, hemodynamics and left ventricular function.
    Gillin AG, Fletcher PJ, Horvath JS, Hutton BF, Bautovich GJ, Tiller DJ.
    Am J Cardiol; 1989 Apr 15; 63(13):950-4. PubMed ID: 2522729
    [Abstract] [Full Text] [Related]

  • 23. Effects of prazosin therapy on BP, renal function, and body fluid composition.
    Bauer JH, Jones LB, Gaddy P.
    Arch Intern Med; 1984 Jun 15; 144(6):1196-200. PubMed ID: 6732379
    [Abstract] [Full Text] [Related]

  • 24. Attenuation of prazosin effect on cardiac output in chronic heart failure.
    Arnold SB, Williams RL, Ports TA, Baughman RA, Benet LZ, Parmley WW, Chatterjee K.
    Ann Intern Med; 1979 Sep 15; 91(3):345-9. PubMed ID: 475164
    [Abstract] [Full Text] [Related]

  • 25. Effects of prazosin on plasma renin activity and blood pressure.
    Karlberg BE, Thulin T, Fagerberg SE, Schersten B, Tolagen K, Vikesdal O, Malmberg L.
    J Clin Pharmacol; 1979 Jul 15; 19(7):357-65. PubMed ID: 479380
    [No Abstract] [Full Text] [Related]

  • 26. Prazosin in hypertension with and without methyldopa.
    Kochar MS, Zeller JR, Itskovitz HD.
    Clin Pharmacol Ther; 1979 Feb 15; 25(2):143-8. PubMed ID: 365428
    [Abstract] [Full Text] [Related]

  • 27. Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure.
    Rubin SA, Chatterjee K, Gelberg HJ, Ports TA, Brundage BH, Parmley WW.
    Am J Cardiol; 1979 Apr 15; 43(4):810-5. PubMed ID: 425918
    [Abstract] [Full Text] [Related]

  • 28. Evidence of decreased plasma substance P levels in human essential hypertension and influence of prazosin treatment.
    Faulhaber HD, Rathsack R, Rostock G, Homuth V, Pfeiffer D, Naumann E, Hartrodt W, Görne RC, Oehme P.
    Biomed Biochim Acta; 1983 Apr 15; 42(7-8):1019-25. PubMed ID: 6197065
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Orthostatic hypotension after the first administration of prazosin in hypertensive patients: role of the plasma volume.
    Semplicini A, Pessina AC, Palatini P, Hlede M, Palù CD.
    Clin Exp Pharmacol Physiol; 1981 Jan 15; 8(1):1-10. PubMed ID: 6162595
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients.
    Feit A, Cohen M, Dimino L, el-Sherif N, Holtzman R, Venkata C, Ram S, Gaffeny D, Heller J, Kaplan N.
    J Hum Hypertens; 1991 Feb 15; 5(1):39-43. PubMed ID: 2041034
    [Abstract] [Full Text] [Related]

  • 37. Comparative effects of pinacidil and prazosin on blood pressure, weight, plasma volume, the renin-angiotensin-aldosterone system, and the renal kallikrein-kinin system in patients with essential hypertension.
    Solomon RJ, Weinberg MS.
    J Clin Hypertens; 1987 Dec 15; 3(4):589-95. PubMed ID: 3330989
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of tiodazosin, a new antihypertensive, hemodynamics and clinical variables.
    Vardan S, Smulyan H, Mookherjee S, Eich R.
    Clin Pharmacol Ther; 1983 Sep 15; 34(3):290-6. PubMed ID: 6883905
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.